This study was to explore the sex differences in clinical characteristics and brain gray matter volume (GMV) alterations in 29 male patients with major depressive disorder (MDDm), 53 female patients with MDD (MDDf), and in 29 male and 53 female matched healthy controls. Maps of GMV were constructed using magnetic resonance imaging data and compared between groups. We evaluated clinical symptoms using the Hamilton Rating Scale for Depression and obtained a total score and five syndrome scores. A two-factor ANCOVA model was specified using SPM8, with sex and diagnosis as the between-subject factors. We found that: (1) significant GMV increase in the left cerebellum and GMV reduction in the bilateral middle temporal gyrus and left ventral medial prefrontal gyrus occurred selectively in male patients, while the GMV reduction in the left lingual gyrus and dorsal medial prefrontal gyrus occurred selectively in female patients; (2) MDDf may have experienced more severe sleep disturbance than MDDm; and (3) the severity of sleep symptom could be predicted by the sex specific brain structural alterations in depressions. These findings suggest that sex specific anatomical alterations existed in MDD, and these alterations were associated with the clinical symptoms.

No abstract

No abstract

The Earth’s geologic record of Milankovitch cycles closely tracks Solar System solutions for the past 50 million years. Prior to 50 million years ago (Ma), however, the solutions lose accuracy rapidly due to chaotic behavior of the Solar System. Here we reconstruct a 10.173 million year-long record from 82.358 Ma to 92.531 Ma of Earth’s orbital parameters from a continental lacustrine sequence in the Songliao Basin, China constrained by four in situ high-resolution radioisotopic U-Pb ages and magnetic reversal stratigraphy. Analysis of thorium and ostracode shell abundance records from the Songliao Basin reveal evidence for two chaotic secular resonance transitions in the orbital motions of Earth and Mars from 85.2 Ma to 91.55 Ma. The evidence validates similar observations in western North American marine stratigraphy. A unique phasing between the observed orbital eccentricity and obliquity modulations may explain the anoxic events that occurred in both marine and continental environments during this time. Taken together, the continental and marine stratigraphic evidence demonstrates a strong global reach of Late Cretaceous Milankovitch cycles, and provides an important constraint on Solar System chaoticity and the calculation of accurate orbital solutions prior to 50 Ma.

As the pathological basis of cardiovascular disease (CVD), atherosclerosis is featured as a chronic inflammation. Hypercholesterolemia is an independent risk factor for CVD. Accumulated studies have shown that hypercholesterolemia is associated with myeloid cell expansion, which stimulates innate and adaptive immune responses, strengthens inflammation, and accelerates atherosclerosis progression. Hematopoietic stem/progenitor cells (HSPC) in bone marrow (BM) expresses a panel of lipoprotein receptors to control cholesterol homeostasis. Deficiency of these receptors abrogates cellular cholesterol efflux, resulting in HSPC proliferation and differentiation in hypercholesterolemic mice. Reduction of the cholesterol level in the lipid rafts by infusion of reconstituted high-density lipoprotein (HDL) or its major apolipoprotein, apoA-I, reverses hypercholesterolemia-induced HSPC expansion. Apart from impaired cholesterol metabolism, inhibition of reactive oxygen species production suppresses HSPC activation and leukocytosis. These data indicate that the mechanisms underlying the effects of hypercholesterolemia on HSPC proliferation and differentiation could be multifaceted. Furthermore, dyslipidemia also regulates HSPC-neighboring cells, resulting in HSPC mobilization. In the article, we review how hypercholesterolemia evokes HSPC activation and mobilization directly or via its modification of BM microenvironment. We hope this review will bring light to finding key molecules to control HSPC expansion, inflammation, and atherosclerosis for the treatment of CVD.